ID: ALA256732

Max Phase: Preclinical

Molecular Formula: C18H25N3O7

Molecular Weight: 395.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCC(=O)N[C@H]1/C(=N/OC(=O)Nc2ccccc2)O[C@H](CO)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C18H25N3O7/c1-2-3-9-13(23)20-14-16(25)15(24)12(10-22)27-17(14)21-28-18(26)19-11-7-5-4-6-8-11/h4-8,12,14-16,22,24-25H,2-3,9-10H2,1H3,(H,19,26)(H,20,23)/b21-17-/t12-,14-,15-,16-/m1/s1

Standard InChI Key:  NUNQIQQEEPOGDJ-JDOAOKHLSA-N

Associated Targets(Human)

N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase 10 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Beta-hexosaminidase 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 395.41Molecular Weight (Monoisotopic): 395.1693AlogP: 0.34#Rotatable Bonds: 7
Polar Surface Area: 149.71Molecular Species: NEUTRALHBA: 8HBD: 5
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.81CX Basic pKa: CX LogP: 0.58CX LogD: 0.58
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.33Np Likeness Score: -0.05

References

1. Stubbs KA, Balcewich M, Mark BL, Vocadlo DJ..  (2007)  Small molecule inhibitors of a glycoside hydrolase attenuate inducible AmpC-mediated beta-lactam resistance.,  282  (29): [PMID:17439950] [10.1074/jbc.m700084200]

Source